Trial intelligence / Profile preview

Programmed dexmedetomidine sedation in non-mechanically ventilated critically ill postoperative ICU patients

ChiCTR-TRC-14004880Phase 4Recruiting

Sponsor
Tianjin Medical University General Hospital
Start
Aug 2014
Modality
Small Molecules
Countries
1
01

Overview

Phase 4, open-label trial of dexmedetomidine (2 arms), sponsored by Tianjin Medical University General Hospital. Primary endpoints: Delirium, Unpleasant ICU experience and 1 more. Started Aug 2014; status: recruiting.

02

Drugs

dexmedetomidine

Beyond the preview

Go deeper on ChiCTR-TRC-14004880.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on ChiCTR-TRC-14004880.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call